Drug Trials Related Topics 
Bio Pharma Dive
SEPTEMBER 8, 2022
Fuller data from Alnylam’s APOLLO-B trial confirm the success reported by the company last month, but won’t end a debate on the degree of benefit offered by its drug
Bio Pharma Dive
NOVEMBER 7, 2022
Buoyed by strong mid-stage study results, the biotech will soon start a cardiovascular outcomes trial of a drug designed to target a genetic risk factor called lipoprotein(a
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
DECEMBER 6, 2022
The decision not to run a Phase 3 trial of their medicine is the latest fallout from U.S. regulators’ recent moves to closely evaluate a class of drugs known as PI3 kinase inhibitors
Bio Pharma Dive
AUGUST 23, 2021
The decision, which follows the recommendation of a data monitoring committee, is yet another setback in the search for more treatments for the neurological disease
Bio Pharma Dive
MAY 24, 2022
The biotech plans to seek FDA approval for its soft-tissue tumor treatment after positive study results. But investors still sent the stock down by nearly 10
Bio Pharma Dive
JULY 28, 2022
Important data from the APOLLO study of the biotech's drug Onpattro are due before the end of August, Alnylam said Thursday
Pharma Phorum
MAY 19, 2022
Phase 2 trials of Beckley Psytech’s psychedelic drug candidates will make use of digital technologies for patient monitoring, thanks to a new partnership with Empatica. The post Beckley adds digital element to its psychedelic drug trials appeared first on.
BioPharma Reporter
OCTOBER 4, 2022
Kibow Biotech is celebrating its 25th anniversary as the company pivots toward developing a drug based on its proprietary probiotic strains that benefit kidney disease suffers.
Pharma Phorum
OCTOBER 27, 2020
US biotech BioSig Technologies has abandoned a phase 2 trial of its antiviral drug merimepodib with Gilead’s Veklury in severe COVID-19 patients, after concluding the safety of the combination was in doubt.
Pharma Times
DECEMBER 4, 2020
LYT-100 will be evaluated in patients with persistent symptoms caused by COVID-19
Pharma Phorum
MAY 7, 2021
DMT is a powerful hallucinogenic drug found in several plants including the South American plant chacruna and when used recreationally is mixed with the ayahuasca plant to make the shamanic brew of the same name. News R&D depression DMT psychedelic drugs
Scienmag
JANUARY 19, 2022
New research suggests manufacturers of newly developed antidepressant drugs have become more forthcoming about clinical trials that don’t pan out. Latest News antidepressant Drug Improved reports review Transparency trials
Scienmag
DECEMBER 20, 2021
Medicine & Health COVID19 digital Drug failed lining silver trial
Pharma Phorum
MAY 14, 2021
China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. Kintor is in talks with the Brazilian health regulator Anvisa about a further trials.
Outsourcing Pharma
AUGUST 29, 2022
The company reports dosing of the first subject in a Phase IIa proof-of-concept study investigating a drug for an autism spectrum disorder related condition. Drug Delivery
Outsourcing Pharma
JANUARY 16, 2023
A Florida doctor has been sent to prison after submitting a false affidavit claiming she had screened children in a clinical study looking at the effectiveness of drugs given to children with asthma when she had not.
BioSpace
JANUARY 28, 2021
Food and Drug Administration (FDA) has cleared an Investigational New Drug application that will allow Boston-based Vertex Pharmaceuticals to proceed with a clinical trial of its investigational stem cell-derived, fully differentiated pancreatic islet cell treatment for type 1 diabetes
Pharma Phorum
AUGUST 6, 2020
Lundbeck has axed a phase 2 trial of a schizophrenia drug, saying that the study was unlikely to meet its efficacy target. The company said it made the decision after a futility analysis indicated that the trial was not likely to succeed, when measured against a standard scale.
Bio Pharma Dive
JANUARY 10, 2023
Moderna’s Stéphane Bancel and Pfizer’s Albert Bourla hinted Monday at greater dealmaking to come for their companies, while Gilead gave investors an update on an important cancer drug trial
Bio Pharma Dive
OCTOBER 31, 2022
Bringing more diversity to clinical trials is a slow process and it takes time to get right. Learn how Worldwide Clinical Trials can diversify the reach of your orphan drug trial
BioSpace
OCTOBER 11, 2020
was convicted on 47 counts of fraud and drug related charges on Oct. A 41-year-old man from Richland, Wash. 1, according to the U.S. Justice Department’s Eastern District of Washington
BioSpace
FEBRUARY 15, 2021
According to a statement made by Cortexyme, the partial hold was placed on the development program for atuzaginstat after an FDA review of the trial data identified hepatic adverse events
BioSpace
OCTOBER 19, 2021
?SURPASS-4 is part of the Phase III trial evaluating tirzepatide as a possible treatment for type 2 diabetes
BioSpace
MARCH 22, 2021
Ionis Pharmaceuticals announced that its collaboration partner, Roche, was discontinuing dosing in the Phase III GENERATION HD1 trial of tominersen in manifest Huntington’s disease (HD
Scienmag
JUNE 15, 2022
A novel staging framework that assesses the progression of Huntington’s disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; this ‘significant’ step paves the way for clinical trials of drugs in the earliest phase of disease. Latest News defines Disease Drug Huntingtons revolutionise system trials
The Pharma Data
JANUARY 20, 2021
Drug Industry Daily (DID) the premier online resource for savvy pharmaceutical professionals whose jobs depend on accurate knowledge about the daily activities of Congress, the FDA, other key regulators … and what their competitors are up to.
The Pharma Data
DECEMBER 8, 2020
The FDA has issued a clinical hold on Bellicum Pharmaceuticals for its ongoing phase 1/2 trial evaluating CAR-T therapy BPX-601 in patients who received prior treatment for metastatic pancreatic or prostate cancer, following the death of a trial participant.
The Pharma Data
OCTOBER 26, 2020
based aTyr Pharma has finalized enrollment for a phase 2 trial to evaluate an investigational anti-inflammatory drug in COVID-19 patients with severe respiratory complications. The double-blind, placebo-controlled trial, which has 32 participants across the U.S.,
Scienmag
JULY 18, 2021
The models allow for virtual trials of drugs and vaccines, opening the possibility of pre-assessment for drug and vaccine efficacy against the virus. Biology Biomedical/Environmental/Chemical Engineering Cell Biology Clinical Trials Diagnostics Disease in the Developing World Epidemiology Infectious/Emerging Diseases Public Health Technology/Engineering/Computer Science Vaccines
XTalks
AUGUST 3, 2022
The drug is the first FDA approved oral suspension form of zonisamide. Hear about how the drug could help increase accessibility and flexibility for epilepsy patients and improve treatment adherence.
Scienmag
JULY 8, 2021
Researchers, including academics from the University of York, analysed systematic reviews of 1,200 Randomised Controlled Trials (RCTs) to assess whether reporting had improved over time. Medicine & Health Clinical Trials Health Professionals Medicine/Health Public HealthHowever, the information the researchers needed to assess what adverse effects were reported (and how they were reported) was only included in less than half of the RCTs they analysed. […].
BioTech 365
JULY 19, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Troubled Cytokinetics’ stock soars as gets much needed phase 2 heart drug trial win, plans late-stage effort by year’s end.Troubled Cytokinetics’ stock soars as gets much needed … Continue reading → #news
BioTech 365
JUNE 17, 2021
Global Mantle Cell Lymphoma Clinical Landscape Market Report 2021: Marketed and Pipeline Drugs, Trials, Key Events, Success Probability, 10-Year Disease Prevalence Forecast, Deals, Revenue Forecasts – ResearchAndMarkets.com Global Mantle Cell Lymphoma Clinical Landscape Market Report 2021: Marketed and Pipeline Drugs, … Continue reading → Business Wire
Outsourcing Pharma
NOVEMBER 1, 2021
A former employee of Tellus Clinical Research in Miami has admitted to charges related to a conspiracy to falsify data on a list of clinical drug trials.
BioSpace
AUGUST 17, 2020
Food and Drug Administration halted a cancer drug trial due to safety concerns Shares of Poseida Therapeutics plunged more than 20% in premarket trading this morning after the company announced the U.S.
BioSpace
OCTOBER 20, 2021
An experimental AstraZeneca cancer drug trial has been placed on hold due to safety concerns. This news comes two years after Amgen was also forced to pause a study of a drug within the same class
World of DTC Marketing
APRIL 20, 2022
Attitudes are indeed changing, but one need remains clear: access to data obtained during clinical and ongoing trials. This was especially true with new drugs that have a significant competitive market.
NY Times
FEBRUARY 10, 2022
The panel debated whether overseas trials could be applied to a more diverse U.S. The decision may affect other Chinese drug trials, and spotlights the high cost of immunotherapy. population.
BioSpace
APRIL 1, 2021
To date, these drug trials have not been particularly successful at i One of the common research approaches to treating brain diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) is using antibodies designed to clear the accumulated misfolded proteins implicated in the diseases.
World of DTC Marketing
AUGUST 9, 2021
The best approach is to use social media to connect HCPs to clincial information and drug trials. A leading pharma company recently sponsored a series of Q&A around the use of their new cancer drug.
World of DTC Marketing
JULY 19, 2021
CDC and new drugs have fostered an era of mistrust with some people. DTC marketers need to be more forthcoming when it comes to drug trials and side effects. This means that trust will be a huge issue for new drugs that promise breakthrough results.
Pharma Phorum
FEBRUARY 19, 2021
million, which uses artificial intelligence (AI) technology to speed up drug development. With the acquisition MindMed gains access to HealthMode’s intellectual property, platforms for clinical drug trials, and its entire 24-strong digital medicine team.
Pharmaceutical Technology
SEPTEMBER 20, 2022
Unlike commercial pharmaceutical packaging, the primary consideration in clinical trial packaging is protecting the product quality and reliability for research. The increasing investment in pharmaceutical research and development, and the growing adoption of contract manufacturing and marketing practices are driving the demand for clinical trial contract packaging solutions. Finding the best clinical trial packaging services providers.
Expert insights. Personalized for you.
303 
Let's personalize your content